• Industry secrets on...

• Industry secrets on...

The Ed Ponsi Forex Playbook offers a visual approach to learning specific trading strategies and identifying profitable trading opportunities in the Forex arena. Page by page, it skillfully describes strategies for long-term trading, swing trading, and day...

As optical character recognition (OCR) begins to find applications ranging from store checkout scanners to money-changing machines and postal system automation, it has become one of the most dynamic areas in information science today. Yet few volumes explore this data-oriented process without relying heavily on mathematical background...

IF YOU are becoming worried about an aspect of your own behaviour - maybe you no longer feel totally in control of it, or are concerned about the health implications, or the fact that it takes up so much of your time and money - and you've decided that you want to do something about it, this book will help you.

You might...

Professionals involved in the planning, design, operation, and construction of water, wastewater, and stormwater systems need to understand the productivity-enhancing applications of GIS. Inspired by an ASCE-sponsored continuing education course taught by the author, GIS Applications for Water, Wastewater, and Stormwater Systems...

Prentice Hall's most important C programming title in years. A companion volume to Kernighan & Ritchie's C PROGRAMMING LANGUAGE. A collection of reusable functions (code for building data structures, code for performing math functions and scientific calculations, etc.) which will save C programmers time and money especially when...

GET PAID TO PLAY! 30 years in the making, the first book to offer everything you need to go from rags to riches in the fabulous videogame industry is here - are you ready to nail the ultimate high score? A must-have for anyone seeking a career in game art, design, audio, programming, marketing, journalism and sales! Learn how to break into...

Pharmaceutical companies are spending increasing amounts of money on drug discovery and development. Nevertheless, attrition rates in clinical development are still very high, and up to 90% of new compounds fail in clinical phase I - III trials, which is partially due to lack of clinical efficacy. This indicates a strong need for highly...